Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

@article{Hansson2000RandomisedTO,
  title={Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study},
  author={Lennart Hansson and Thomas Hedner and Per Lund-Johansen and Sverre Erik Kjeldsen and Lars Lindholm and Jan Otto Syvertsen and Jan Lanke and Ulf de Faire and Bj{\"o}rn Dahl{\"o}f and BengtE. Karlberg},
  journal={The Lancet},
  year={2000},
  volume={356},
  pages={359-365}
}
BACKGROUND Calcium antagonists are a first-line treatment for hypertension. The effectiveness of diltiazem, a non-dihydropyridine calcium antagonist, in reducing cardiovascular morbidity or mortality is unclear. We compared the effects of diltiazem with that of diuretics, beta-blockers, or both on cardiovascular morbidity and mortality in hypertensive patients. METHODS In a prospective, randomised, open, blinded endpoint study, we enrolled 10,881 patients, aged 50-74 years, at health centres… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 243 CITATIONS, ESTIMATED 44% COVERAGE

572 Citations

0204060'00'04'09'14'19
Citations per Year
Semantic Scholar estimates that this publication has 572 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

Implications of discontinuation of doxazosin arm of ALLHAT

  • JA Staessen, WH Birkenhäger, RH Fagard
  • Lancet
  • 2000

Similar Papers

Loading similar papers…